Podcast

Andrew Solomon, MD, on Managing MS Symptoms

07/22/2019

 

In this podcast, Andrew Solomon, MD, discusses multiple sclerosis therapies for symptom management. He overviews spasticity; neuropathic pain; fatigue; and bladder, bowel, and sexual dysfunction as symptoms caused by multiple sclerosis.

Additional Resource:
Solomon AJ. Multiple sclerosis therapy: symptom management. Paper presented at: American Academy of Neurology Annual Meeting 2019; May 4-10, 2019; Philadelphia, PA. http://tools.aan.com/annualmeeting/search/?fuseaction=home.detail&id=7054.

 

Andrew J. Solomon, MD, is an associate professor of neurological sciences and chief of the multiple sclerosis division at the Larner College of Medicine at the University of Vermont.

Related Content

Rheumatology
Rheumatology
Tanaz Kermani, MD, on ANCA-Associated Vasculitis Treatment Strategies
05/27/2012
In this podcast, Tanaz Kermani, MD, MS, provides an in-depth overview of antineutrophil cytoplasmic antibody-associated vasculitis treatment strategies.
05/27/2012
Cardiovascular Diseases
Cardiovascular Diseases
Seth Baum, MD, on PCSK9 Inhibitors: The Good, The Bad, and The Future
08/30/2017
<p>Dr Seth Baum, President of the American Society for Preventive Cardiology, discusses his recent paper on PCSK9 inhibitors.</p>
08/30/2017
Infectious Diseases
Infectious Diseases
Shane Crotty, PhD, on Engineering Vaccine Immunity
04/21/2020
He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
04/21/2020
Multiple Sclerosis
Multiple Sclerosis
Francisco Quintana, PhD, on Astrocyte Pathogenic Activities in MS
01/28/2020
Francisco Quintana, PhD, from Harvard Medical School, talks about his research on molecular control of astrocyte pathogenic activities in multiple sclerosis (MS), including novel astrocytes and their role...
01/28/2020
disease progression
disease progression
George Karpouzas, MD, on β-2 Glycoprotein 1 IgA Antibodies and Coronary Outcomes in RA
03/22/2022
Dr Karpouzas discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of...
03/22/2022